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Background: In well-child care it is difficult to determine whether preschool children with asthma symptoms
actually have or will develop asthma at school age. The PIAMA (Prevention and Incidence of Asthma and Mite
Allergy) Risk Score has been proposed as an instrument that predicts asthma at school age, using eight easy
obtainable parameters, assessed at the time of first asthma symptoms at preschool age. The aim of this study is to
present the rationale and design of a study 1) to externally validate and update the PIAMA Risk Score, 2) to develop
an Asthma Risk Appraisal Tool to predict asthma at school age in (specific subgroups of) preschool children with
asthma symptoms and 3) to test implementation of the Asthma Risk Appraisal Tool in well-child care.
Methods and design: The study will be performed within the framework of Generation R, a prospective
multi-ethnic cohort study. In total, consent for postnatal follow-up was obtained from 7893 children, born between
2002 and 2006. At preschool age the PIAMA Risk Score will be assessed and used to predict asthma at school age.
Discrimination (C-index) and calibration will be assessed for the external validation. We will study whether the
predictive ability of the PIAMA Risk Score can be improved by removing or adding predictors (e.g. preterm birth).
The (updated) PIAMA Risk Score will be converted to the Asthma Risk Appraisal Tool- to predict asthma at school
age in preschool children with asthma symptoms. Additionally, we will conduct a pilot study to test
implementation of the Asthma Risk Appraisal Tool in well-child care.
Discussion: Application of the Asthma Risk Appraisal Tool in well-child care will help to distinguish preschool
children at high- and low-risk of developing asthma at school age when asthma symptoms appear.
This study will increase knowledge about the validity of the PIAMA risk score and might improve risk assessment of
developing asthma at school age in (specific subgroups of) preschool children, who present with asthma
symptoms at well-child care.
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Asthma symptoms in preschool children are non-
specific. It is therefore difficult to determine which pre-
school children with asthma symptoms actually have or
will develop asthma at school age [1]. A recent study
has shown that both undertreatment and overtreatment
of asthma in children between ages 2 and 8 years seem
common [2]. Inadequate risk assessment of asthma
when children present with asthma symptoms at well-
child care may be an important cause of inadequate* Correspondence: e.hafkamp@erasmusmc.nl
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distribution, and reproduction in any mediumtreatment of childhood asthma. To improve early diag-
nosis and management of asthma symptoms, we rea-
soned that early detection of preschool children at high
risk of developing asthma at school age is important.
In this study we present the rationale and design of a
study focusing on risk assessment of asthma in well-
child care. Well-child care physicians and nurses have
routine contact with about 90% of all preschool children
and their families [3] and therefore can play an import-
ant role in 1) early detection of children with asthma
symptoms in the general population, 2) risk assessment
of asthma in early detected children and 3) adequate
monitoring and counselling of children at high risk of
asthma. The first and third step are currently beinged Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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effectivity of early detection and counselling of preschool
asthma symptoms within well-child care’ [4]. However,
the second step of asthma risk assessment in children
who are detected early in life is not yet available within
well-child care. There is a need for an Asthma Risk Ap-
praisal Tool to support well-child care professionals
when a preschool child presents with asthma symptoms.
To estimate the risk of developing asthma at school
age at the time children have asthma symptoms in pre-
school years, a risk score (i.e. prediction model) may be
a suitable tool. A tool like this could support the com-
munication between well-child care professionals and
parents of children at risk of developing asthma. Several
studies previously developed a prediction model for
asthma [5-12]. It is complicated to compare these stud-
ies, because definitions and age of asthma differed. Many
studies used information up to a fixed age, irrespective
of the age of symptom onset [6,8,10,11]. The PIAMA
(Prevention and Incidence of Asthma and Mite Allergy)
Risk Score has been proposed as an instrument that pre-
dicts asthma at age 7–8 years, using eight easy obtain-
able parameters, assessed at the time of first asthma
symptoms at preschool age [7]. The PIAMA Risk Score
discriminated between asthmatic and non-asthmatic
children (internally validated area under the curve,
AUC = 0.72) and may be a suitable tool for use in
well-child care. Prediction models are mathematical
models based on available patient data from a certain
setting. Before use of a prediction model can be recom-
mended in practice, external validation is mandatory to
determine the ability of a model to reliably predict the
outcome in other populations and settings [7].
The main objective is to present the rationale and de-
sign of a study to externally validate and update the
PIAMA Risk Score. Furthermore, an Asthma Risk Ap-
praisal Tool will be developed to predict asthma at
school age in (specific subgroups of) preschool children
with asthma symptoms. We will conduct a pilot test of
the Asthma Risk Appraisal Tool within well-child care.
By describing the rationale and design of our study we
give insight into the framework of our study. This frame-
work concerns the process of external validation and
updating of a prediction rule, development of an applica-
tion tool and assessment of whether the tool can be
implemented into practice. This study will help others to
convert prediction rules into practice.
Methods and design
Design and setting
Our study will be embedded in Generation R, a prospective
population-based, multi-ethnic cohort study. In total, con-
sent for postnatal follow-up was obtained from 7893 chil-
dren, born between April 2002 and January 2006 [13].Questionnaires for parental completion, partly based on the
International Study of Asthma and Allergies in Childhood
(ISAAC) core questionnaires [14], were sent to the parents
during pregnancy and when the children were aged 1, 2, 3,
4 and 6 years (N=7893) [15]. Response rates for these ques-
tionnaires were 71%, 76%, 72%, 73% and 68% respectively.
Data collection at child’s age of 9 years is currently ongoing.
In this study, children will be included if at least one posi-
tive response was given to the following questions in the
annual questionnaires at age 1 to 4 years: “Has your child
had wheezing in the last 12 months?” and “Has your child
had cough during the night, when he/she did not have a
cold or a chest infection, in the last 12 months?” The
present study was conducted in accordance with the guide-
lines proposed in the Declaration of Helsinki, and is
approved by the Medical Ethical Committee of the Erasmus
Medical Centre (MEC 217.595/2002/202). Written consent
was obtained from all participating parents.
Asthma outcomes
The outcome that is predicted with the PIAMA Risk
Score is asthma at school age. In the development study
(PIAMA) the following 3 items were used for the case
definition of asthma: (1) at least 1 episode of wheezing
in the last 12 months; (2) inhaled steroids prescribed by
a medical doctor in the last 12 months; and (3) a doc-
tor’s diagnosis of asthma (a parental report of a doctor’s
diagnosis of asthma at any time and a parental report of
asthma in the last 12 months). In the analyses children
were only considered positive for asthma if they had 1
or more positive items at age 7 years and 1 or more
positive items at age 8 years [7].
Within the validation data (Generation R), we aim to
use the same asthma definition as used in PIAMA and
we aim to select only children with ‘active asthma’ or
clinically relevant chronic asthma symptoms. First, we
will define asthma at the age of 6 years in the children
who have ever had reported asthma symptoms before
the age of 4 years. Additionally, the analyses will be
repeated in children at age 9 years. At age 9 years
spirometry will be performed in children at the research
center. Spirometry is used to improve the accuracy of an
asthma diagnoses and will be enable us to compare
asthma outcomes based on parental reports to asthma
outcomes based on spirometry.
Preschool predictors
The eight predictor variables used in the PIAMA Risk
Score are: 1) sex, 2) post-term delivery, 3) parental educa-
tion, 4) parental inhalation medication, 5) child’s wheezing
frequency, 6) wheezing/dyspnea apart from colds, 7) serious
infections and 8) doctor’s diagnosis of eczema and eczema-
tous rash present. The variables wheezing/dyspnea apart
from colds and parental inhalation medication are not
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For parental inhalation medication a proxy variable of
parental asthma is available. Information on sex and preg-
nancy duration are obtained from medical records; parental
education and asthma are established using questionnaires
during pregnancy; wheezing frequency, respiratory tract
infections and eczema are measured using questionnaires
at the ages of 1, 2, 3 and 4 years.External validation
As a first step we will compare the distribution of the pre-
dictors of the PIAMA Risk Score and the asthma outcome
in the development (PIAMA) and validation (Generation
R) data to determine whether the datasets are comparable.
Univariate logistic regression analyses will be performed
to establish the effect of the different predictors on asthma
at the age of 6 and 9 years. The resulting univariate odds
ratios (ORs) will be compared with ORs in the develop-
ment sample as reported for the PIAMA model. Next, the
multivariate PIAMA model will be fitted in the validation
sample to compare the multivariate ORs. Finally we will
calculate the predicted probability to develop asthma for
each child in the validation sample, based on the PIAMA
score. These predicted probabilities are used to assess the
external validity of the PIAMA model, in terms of calibra-
tion and discrimination. Calibration refers to the agree-
ment between observed and predicted outcomes. The
extent of over- or underestimation relative to the observed
and predicted rate will be explored graphically using valid-
ation plots. We will assess calibration-in-the-large by fit-
ting a logistic regression model with the model
predictions as an offset variable. The intercept indicates
whether predictions are systematically too low or too high,
and should ideally be zero. The calibration slope reflects
the average effects of the predictors in the model and will
be estimated in a logistic regression model with the logit
of the model predictions as the only predictor. For a per-
fect model, the slope is equal to 1. The Concordance-
index (C-index) or Area Under the receiver operating
characteristic Curve (AUC) and 95% confidence interval
(CI) will be used to assess the ability of the model to dis-
criminate children with and without asthma. The external
validation will also be performed in specific subgroups
(e.g. at different ages or in ethnic and socioeconomic
subgroups of preschool children, see subgroup analysis).
To interpret any differences in C-indices, we will con-
sider benchmark values as recently proposed [16].Updating
After external validation we will assess whether the pre-
dictive performance of the PIAMA model remains stable
or improves by deleting or adding predictors that are
available in the validation data.By removing predictors, a more simple risk score will be
created. The predictive performance of such a simple risk
score will be compared with the predictive performance of
the PIAMA Risk Score. A simpler risk score is preferable
for application in practice [17]. Potential additional predic-
tors include e.g. child’s ethnicity, preterm birth, sleeping
problems due to asthma symptoms, doctor visits due to
asthma symptoms, wheezing patterns, allergy or general
health. To study the prognostic value of additional predic-
tors, we will refit the PIAMA Risk Score in the validation
data and consequently add the new predictors. We will cal-
culate the increase in AUC with 95% CI, and the p-value
from the likelihood ratio test for improvement of goodness
of fit. This will result in an updated PIAMA Risk Score. For
optimal precision of the estimated coefficients, the updated
PIAMA Risk Score will be fitted to the combined PIAMA
and Generation R data.
Subgroup analysis
The PIAMA Risk Score was developed within a general
population. However, it is known that children of ethnic mi-
norities and children with low socioeconomic status are at
high risk of developing asthma. Within well-child care it is
important to give attention to high risk groups. Therefore,
it is important to test the predictive ability of the PIAMA
Risk Score in both the general population and in specific
subgroups (e.g. at different ages or in children of ethnic mi-
norities and children with low socioeconomic status).
Development of asthma risk appraisal tool
We will convert the updated PIAMA Risk Score to a
computer-assisted tool, the so called ‘Asthma Risk Appraisal
Tool’. The best cut-off scores of the Asthma Risk Appraisal
Tool will be studied within the validation study. In an ex-
pert meeting we will discuss which decisions will follow the
cut-offs: referral to general practitioner (=indirect referral to
pediatrician)/ asthma nurse, extra consultation moment at
well-child care, personal advise/counselling. The aim is to
create an easy applicable (computer-assisted) tool for use of
the PIAMA Risk Score in well-child care. A previous study
developed a similar risk assessment tool to early detect chil-
dren with global developmental disabilities in well-child
care [18]. A computer-assisted risk assessment tool height-
ens the uniformity of practice.
Pilot testing
After development of the Asthma Risk Appraisal Tool, the
tool will be tested in a pilot study within well-child care.
The pilot test will be conducted in the Rotterdam-
Rijnmond area that contains both rural and metropolitan
and ethnically diverse sub-regions. The implementation will
involve 3 varied well-child care teams (including one or
more well-child care physicians, nurses and medical assis-
tants per team that provide services to a certain group of
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aimed to pilot the Asthma Risk Appraisal Tool to
100 children/families. So, a total of 300 children/families
are aimed to be included in the pilot study.
When children present with asthma symptoms, the
Asthma Risk Appraisal Tool will be applied. In the pilot
study we will assess how many preschool children were
detected as high-risk of developing asthma at the ages of
6 and 9 years by the Asthma Risk Appraisal Tool. We
will evaluate which decisions cq. actions were taken by
physicians/nurses after the use of the Asthma Risk Ap-
praisal Tool (and how many times). Evaluation of the ef-
fectivity of implementation of the Asthma Risk
Appraisal Tool in well-child care practice is outside the
framework of this study.
Sample size
At least 100 patients with the outcome and 100 without
the outcome are needed for reliable external validation
of a prediction model [19].
Sample size at the age of 6 years: Assuming a preva-
lence of asthma of 5% at the age of 6 years (and it is
known that 3967 children have ever had asthma symp-
toms at the age of 4 years) the Generation R study will
have approximately 198 children aged 6 years [19]. This
implies that our effective sample size at the age of 6
years is sufficiently large for the primary aim of this
study.
Discussion
We present the rationale and design of a study to exter-
nally validate and update the PIAMA Risk Score and to
develop and test an application of the PIAMA Risk
Score to predict asthma at school age in (specific sub-
groups of ) preschool children with asthma symptoms.
This Asthma Risk Appraisal Tool might be used in well-
child care as an Asthma Risk Appraisal Tool in pre-
school children already detected with asthma symptoms.
Several studies previously developed a prediction
model to predict asthma [5-12]. It is complicated to
compare these studies, because definitions and age of
asthma differs and it is unknown which definition of
asthma truly identifies the disease. Many studies used in-
formation up to a fixed age irrespective of the age of
symptom onset [6,8,10,11]. Some of the prediction mod-
els included blood tests [6,11,12]. Prediction models in-
cluding blood tests are not feasible in well-child care,
given the (very) low acceptance of drawing blood in the
setting of prevention by parents and children, the lack of
funding for laboratory tests in preventive healthcare, and
because laboratory results should be awaited. Therefore,
the PIAMA Risk Score - including only easy obtainable
parameters - is preferred above prediction models in-
cluding blood tests. The PIAMA Risk Score has beencompared to the asthma predictive index developed by
Castro-Rodriquez et al. [6] and showed a better predict-
ive ability, and also performed better than a doctors
diagnosis of asthma at the same age [7].
This study benefits from a longitudinal design, which
enables us to collect repeated measurements of predic-
tors at preschool age. In this way we can identify the age
at onset of first symptoms, unlike some earlier studies
who predict asthma at fixed ages [6,8,10,11]. The ages at
which asthma symptoms appear most frequently is the
time that children will regularly visit well-child care and
when prediction of asthma becomes relevant. Further-
more, there will be little differences in design and ana-
lysis between the development and the validation study.
It is our intention to develop an Asthma Risk Appraisal
Tool integrated in well-child care at preschool age in
such a way that it has maximal opportunity for future
wide-spread implementation, once proved useful.
There are several reasons why early detection followed
by risk assessment of asthma is important: early detec-
tion of preschool children at high risk of developing
asthma at school age will contribute to adequate and
early management, resulting in fewer asthma symptoms,
while improving child’s quality of life [4,20]. Further-
more, for parents of preschool children it is important
to know the risk of developing asthma at school age,
and the options for treatment or intervention to reduce
or prevent progression of asthma symptoms.
Risk assessment is important because in well-child care
(in the Netherlands) task reallocation is ongoing: an ap-
proach where children and families with the highest risks
on health and psychosocial problems receive higher levels
of preventive care and monitoring. Those with low risk of
health and psychosocial problems should be offered care
at a basic level in terms of frequency, content and type of
professional. The background of this approach is often
budgetary pressure. In most cases nowadays, risk selection
is carried out by a trained healthcare assistant based on
predefined factors at preschool age (e.g. socioeconomic
status, single parenting, child health, paternal psychopath-
ology). Although child’s health at preschool age is one of
the factors which is included in the approach of risk selec-
tion at school age, no specific attention is given to pre-
school child’s asthma symptoms or preschool child’s risk
of developing asthma at school age. To prevent inadequate
treatment of childhood asthma and to prevent that chil-
dren with an increased risk of asthma are lost to follow up
by primary and secondary healthcare, it is important to
assess the risk of developing asthma at school age when
preschool children present with asthma symptoms at
well-child care.
The aim of improved risk assessment of asthma is to
achieve optimal asthma management without delay in
preschool children with symptoms suggestive of asthma
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aim of optimal asthma management is to reduce and
prevent the burden of asthma in the future and to im-
prove the child’s quality of life. However, this topic is
outside the framework of this study. After pilot testing
and implementation, a randomised controlled trial is a
possible next step to evaluate the effectivity of the use of
an Asthma Risk Appraisal Tool in well-child care to sup-
port professionals in risk assessment of asthma, when
preschool children present with asthma symptoms.
Conclusion
This study will increase knowledge about the external
validity of the PIAMA risk score and might improve risk
assessment of developing asthma at school age in (spe-
cific subgroups of ) preschool children, who present with
asthma symptoms at well-child care.
Abbreviations
C-index: Concordance-index; ISAAC: International study of asthma and
allergies in childhood; ORs: Odds ratios; PIAMA: Prevention and incidence of
asthma and mite allergy.
Competing interests
All authors declare that they have no competing interests.
Authors’ contributions
The study was initiated by EH and HR. HL, DC, AW, VWV, JCJ, ES and HR
participated in the study concept and design. All authors reviewed and
approved the final version of this manuscript.
Acknowledgements
We gratefully acknowledge the contribution of children and parents, general
practitioners, hospitals and midwives in Rotterdam.
Author details
1The Generation R Study Group, Erasmus MC, Rotterdam, The Netherlands.
2Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
3Department of Paediatrics, Division of Respiratory Medicine, Erasmus MC-
Sophia Children’s Hospital, Rotterdam, The Netherlands. 4Centre for
Prevention and Health Services Research / National Institute for Public Health
and the Environment, Bilthoven, The Netherlands. 5Department of
Epidemiology, Erasmus MC, Rotterdam, The Netherlands. 6Department of
Paediatrics, Erasmus MC-Sophia Children’s Hospital, Rotterdam,
The Netherlands.
Received: 25 September 2012 Accepted: 12 October 2012
Published: 16 October 2012
References
1. Martinez FD: What have we learned from the Tucson Children’s
Respiratory Study? Paediatr Respir Rev 2002, 3:193–197.
2. Caudri D, Wijga AH, Smit HA, Koppelman GH, Kerkhof M, Hoekstra MO,
Brunekreef B, de Jongste JC: Asthma symptoms and medication in the
PIAMA birth cohort: evidence for under and overtreatment. Pediatr
Allergy Immunol 2011, 22:652–659.
3. Buijze H, Jawad J, van der Kort G, Korthuis SE, van der Lei J, Mink M,
Nijendaal G, Potting SMC, Roest E, Schilthuis HJ, et al: Evaluatie
Jeugdgezondheidszorg 2006. Leiden: TNO and Van Naem & Partners; 2006.
4. Hafkamp-de Groen E, Mohangoo AD, de Jongste JC, Van der Wouden JC,
Moll HA, Jaddoe VW, Hofman A, de Koning HJ, Raat H: Early detection and
counselling intervention of asthma symptoms in preschool children:
study design of a cluster randomised controlled trial. BMC Publ Health
2010, 10:555.5. Balemans WA, van der Ent CK, Schilder AG, Sanders EA, Zielhuis GA, Rovers
MM: Prediction of asthma in young adults using childhood characteristics:
Development of a prediction rule. J Clin Epidemiol 2006, 59:1207–1212.
6. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD: A clinical index to
define risk of asthma in young children with recurrent wheezing. Am J
Respir Crit Care Med 2000, 162:1403–1406.
7. Caudri D, Wijga A, Schipper CM, Hoekstra M, Postma DS, Koppelman GH,
Brunekreef B, Smit HA, de Jongste JC: Predicting the long-term
prognosis of children with symptoms suggestive of asthma at
preschool age. J Allergy Clin Immunol 2009, 124:903–910. e901-907.
8. Devulapalli CS, Carlsen KC, Haland G, Munthe-Kaas MC, Pettersen M,
Mowinckel P, Carlsen KH: Severity of obstructive airways disease by age 2
years predicts asthma at 10 years of age. Thorax 2008, 63:8–13.
9. Eysink PE, ter Riet G, Aalberse RC, van Aalderen WM, Roos CM, van der Zee
JS, Bindels PJ: Accuracy of specific IgE in the prediction of asthma:
development of a scoring formula for general practice. Br J Gen Pract
2005, 55:125–131.
10. Kurukulaaratchy RJ, Matthews S, Holgate ST, Arshad SH: Predicting
persistent disease among children who wheeze during early life. Eur
Respir J 2003, 22:767–771.
11. Matricardi PM, Illi S, Gruber C, Keil T, Nickel R, Wahn U, Lau S: Wheezing in
childhood: incidence, longitudinal patterns and factors predicting
persistence. Eur Respir J 2008, 32:585–592.
12. Wever-Hess J, Kouwenberg JM, Duiverman EJ, Hermans J, Wever AM:
Prognostic characteristics of asthma diagnosis in early childhood in
clinical practice. Acta Paediatr 1999, 88:827–834.
13. Jaddoe VW, van Duijn CM, van der Heijden AJ, Mackenbach JP, Moll HA,
Steegers EA, Tiemeier H, Uitterlinden AG, Verhulst FC, Hofman A: The
Generation R Study: design and cohort update 2010. Eur J Epidemiol
2010, 25:823–841.
14. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA,
Pearce N, Sibbald B, Stewart AW, et al: International Study of Asthma and
Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995,
8:483–491.
15. Sole D, Vanna AT, Yamada E, Rizzo MC, Naspitz CK: International Study of
Asthma and Allergies in Childhood (ISAAC) written questionnaire:
validation of the asthma component among Brazilian children. J Investig
Allergol Clin Immunol 1998, 8:376–382.
16. Vergouwe Y, Moons KG, Steyerberg EW: External validity of risk models:
Use of benchmark values to disentangle a case-mix effect from incorrect
coefficients. Am J Epidemiol 2010, 172:971–980.
17. Leonardi NA, Spycher BD, Strippoli MP, Frey U, Silverman M, Kuehni CE:
Validation of the Asthma Predictive Index and comparison with simpler
clinical prediction rules. J Allergy Clin Immunol 2011, 127:1466–1472. e1466.
18. Dusseldorp E, Boere-Boonekamp MM, Coenen-Van Vroonhoven E: Pilotstudie
D-screening: screening op ontwikkelingsachterstand bij het jonge kind,
uitgevoerd door de jeugdarts. Leiden: TNO; 2011.
19. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD: Substantial
effective sample sizes were required for external validation studies of
predictive logistic regression models. J Clin Epidemiol 2005, 58:475–483.
20. Van den Boom G: Early detection and medical treatment of asthma and
COPD in general practice [PhD Thesis]. Katholieke Universiteit Nijmegen:
University Press Nijmegen; 2000.
doi:10.1186/1471-2466-12-65
Cite this article as: Hafkamp-de Groen et al.: Predicting asthma in
preschool children with asthma symptoms: study rationale and design.
BMC Pulmonary Medicine 2012 12:65.
